Trending
- Pfizer’s Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound
- Wisconsin’s domestic cyclosporiasis cases nearly double in a week
- Officials investigate recruit’s death after routine training event at Camp Pendleton
- KATSEYE’s Sophia Laforteza Announces Hiatus Due to Mental Health
- Xiaomi announces its home and lifestyle sub
- New fatal infection case prompts warnings about coastal bacteria
- Why have obesity rates doubled since 1993?
- Lawsuit: Blind people can’t use Planet Fitness website
Friday, August 7

